Opticyte, Inc.

Seattle, WA 98105

SBIR Award Summary

Total Number of Awards 3
Total Value of Awards $1.15MM
Active Awards 1 valued at $500K
First Award Date 04/01/15
Most Recent Award Date 08/01/17

Key Personnel

Last Name Name Awards Contact
ARAKAKI LORILEE S. L. ARAKAKI 3

3 Awards Won

Phase 2 SBIR Active

Agency: Department of Health & Human Services
Topic: RFA-HL-15-019
Budget: 08/01/17 - 07/31/18

ABSTRACT Clinical thresholds for blood transfusions vary by illness and medical specialty, and are largely based on anecdotal experience. Measured hematocrit is the most frequent determinant for clinical decisions to transfuse blood, often resulting in a one-size-fits-all approach. Although lifesaving at times, blood transfusions have also been...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: RFA-HL-15-019
Budget: 08/15/16 - 07/31/17

ABSTRACT Clinical thresholds for blood transfusions vary by illness and medical specialty, and are largely basedon anecdotal experience. Measured hematocrit is the most frequent determinant for clinical decisions totransfuse blood, often resulting in a one-size-fits-all approach. Although lifesaving at times, bloodtransfusions have also been cle...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: RFA-HL-15-007
Budget: 04/01/15 - 03/31/16

DESCRIPTION (provided by applicant): Critically ill patients commonly arrive at an intensive care unit with anemia. While blood transfusions are the standard of care with the intention to increase or maintain oxygen delivery to tissues, questions have been raised about the benefit of blood transfusions, particularly in non-bleeding patients with...